The ReSPECT-LM single-dose escalation trial assessed the safety, tolerability, and potential efficacy of intrathecally administered Rhenium (186Re) Obisbemeda in patients with leptomeningeal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback